|
ZNF512 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.038400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.597000E-01 |
| Normal-vs-Stage2 |
6.219200E-01 |
| Normal-vs-Stage3 |
6.496000E-01 |
| Normal-vs-Stage4 |
5.782600E-01 |
| Stage1-vs-Stage2 |
8.643200E-01 |
| Stage1-vs-Stage3 |
3.457800E-01 |
| Stage1-vs-Stage4 |
3.744800E-01 |
| Stage2-vs-Stage3 |
4.617600E-01 |
| Stage2-vs-Stage4 |
4.476400E-01 |
| Stage3-vs-Stage4 |
8.241200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.800000E-01 |
| Normal-vs-AfricanAmerican |
5.700600E-01 |
| Normal-vs-Asian |
3.495000E-01 |
| Caucasian-vs-AfricanAmerican |
6.380600E-01 |
| Caucasian-vs-Asian |
4.117000E-01 |
| AfricanAmerican-vs-Asian |
4.436000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.513400E-01 |
| Normal-vs-Female |
4.211900E-02 |
| Male-vs-Female |
7.936100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.121000E-01 |
| Normal-vs-Extreme_Weight |
9.180800E-01 |
| Normal-vs-Obese |
9.039800E-02 |
| Normal-vs-Extreme_Obese |
3.062400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.156200E-01 |
| Normal_Weight-vs-Obese |
3.450100E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.945800E-01 |
| Extreme_Weight-vs-Obese |
1.297370E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.944200E-01 |
| Obese-vs-Extreme_Obese |
1.518160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.870800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.314300E-02 |
| Normal-vs-Age(61-80Yrs) |
7.036000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.523200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.258000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.178000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.992780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.161800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.351900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.867400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.912490E-02 |
| Normal-VS-Type2 PRCC |
1.057650E-01 |
| Normal-VS-KIRP CIMP |
2.219500E-02 |
| Normal-VS-Unclassified PRCC |
8.498100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.826000E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.568500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.813200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.063400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.016460E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.602300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.605430E-01 |
| Normal-vs-N1 |
3.482000E-01 |
| Normal-vs-N2 |
2.841400E-01 |
| N0-vs-N1 |
1.688610E-01 |
| N0-vs-N2 |
1.844780E-01 |
| N1-vs-N2 |
9.458400E-01 |
|
|
